Flerie AB Logo

Flerie AB

FLERIE | ST

Overview

Corporate Details

ISIN(s):
SE0022447348
LEI:
54930047C4A74IBXR037
Country:
Sweden
Address:
BERZELIUS VÄG 13, 171 65 Solna
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations. Flerie was established in 2011 by Thomas Eldered, who co-founded and built one of the global top five drug manufacturers, Recipharm. Dr Carl-Johan Spak, now Senior Advisor, and Thomas laid the foundation for Flerie’s evergreen strategy and oversaw the early investments. Flerie sold Cormorant Pharmaceuticals to BMS in 2016 and Cobra Biologics to Cognate Bioservices in early 2020 – this enabled further investments. In 2018, Dr Ted Fjällman, then chief executive of one of the portfolio companies, joined as Venture Partner, later Partner and CEO of Flerie.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Flerie AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-08 15:30
Delisting Announcement
Bolagsverket har lämnat tillstånd att verkställa fusionsplanen mellan Flerie oc…
Swedish 44.9 KB
2025-08-08 15:30
Delisting Announcement
The Swedish Companies Registration Office has granted permission to implement t…
English 51.6 KB
2025-08-04 08:00
Net Asset Value
SUBSTANSVÄRDE – 31 juli 2025
Swedish 43.5 KB
2025-08-04 08:00
Net Asset Value
NET ASSET VALUE – 31 July 2025
English 43.0 KB
2025-07-31 09:00
Share Issue/Capital Change
Styrelsen i Flerie beslutar om inlösen av samtliga aktier av serie C inom ramen…
Swedish 33.5 KB
2025-07-31 09:00
Share Issue/Capital Change
The Board of Directors of Flerie has resolved to redeem all Series C shares wit…
English 42.1 KB
2025-07-31 08:00
Interim Report
Swedish 1.3 MB
2025-07-31 08:00
Interim Report
English 1.6 MB
2025-07-16 08:00
M&A Activity
Flerie AB:s dotterbolag Flerie Invest AB offentliggör slutligt utfall avseende …
Swedish 49.2 KB
2025-07-16 08:00
M&A Activity
Flerie AB’s subsidiary Flerie Invest AB announces final outcome of the mandator…
English 48.3 KB
2025-07-03 08:00
Net Asset Value
SUBSTANSVÄRDE – 30 juni 2025
Swedish 43.5 KB
2025-07-03 08:00
Net Asset Value
NET ASSET VALUE – 30 June 2025
English 43.1 KB
2025-07-01 08:00
Share Issue/Capital Change
Styrelsen i Flerie beslutar om omvandling av stamaktier till aktier av serie C …
Swedish 42.3 KB
2025-07-01 08:00
Share Issue/Capital Change
The Board of Directors of Flerie has resolved to convert ordinary shares into S…
English 42.3 KB
2025-06-16 10:00
M&A Activity
Flerie AB's subsidiary Flerie Invest AB publish the offer document for the mand…
English 47.2 KB

Automate Your Workflow. Get a real-time feed of all Flerie AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Flerie AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SEIKAGAKU CORPORATION Logo SEIKAGAKU CORPORATION Japan 4548
Selvita S.A. Logo Selvita S.A. Poland SLV
SHEARWATER GROUP PLC Logo SHEARWATER GROUP PLC United Kingdom SWG
Shedir Pharma Group Logo Shedir Pharma Group Italy SHE
Shionogi & Co.,Ltd. Logo Shionogi & Co.,Ltd. Japan 4507
Simris Group AB Logo Simris Group AB Sweden SIMRIS
SKILLCAST GROUP PLC Logo SKILLCAST GROUP PLC United Kingdom SKL
Solasia Pharma K.K. Logo Solasia Pharma K.K. Japan 4597
Sopharma AD Logo Sopharma AD Bulgaria SFA
STADA Arzneimittel AG Logo STADA Arzneimittel AG Germany SAZ